THREE-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL: LATE CLINICAL OUTCOMES WITH BIORESORBABLE COMPARED TO PERMANENT POLYMER EVEROLIMUS-ELUTING

被引：1
|
作者：
Kereiakes, Dean J. [1 ]
Meredith, Ian [1 ]
Windecker, Stephan [1 ]
Rodes-Cabau, Josep [1 ]
Lee, Tommy [1 ]
Reitman, Arthur [1 ]
Erglis, Andrejs [1 ]
Dorogy, Mark [1 ]
Bertolet, Barry [1 ]
Cannon, Louis [1 ]
Airaksinen, Juhani [1 ]
Siegel, Craig [1 ]
Christen, Thomas [1 ]
Allocco, Dominic [1 ]
Dawkins, Keith [1 ]
机构：
[1] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(17)34359-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1135M-09
引用
收藏
页码：970 / 970
页数：1
相关论文
共 50 条
  • [21] Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
    Katagiri, Yuki
    Onuma, Yoshinobu
    Asano, Taku
    Iniguez, Andres
    Jensen, Lisette Okkels
    Cequier, Angel
    Hofma, Sjoerd H.
    Christiansen, Evald H.
    Suttorp, Maarten
    Brugaletta, Salvatore
    Raeber, Lorenz
    Sabate, Manel
    Windecker, Stephan
    Serruys, Patrick W.
    EUROINTERVENTION, 2018, 14 (11) : 1224 - 1226
  • [22] Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial
    Onuma, Yosinobu
    Serruys, Patrick W.
    Ormiston, John A.
    Regar, Evelyn
    Webster, Mark
    Thuesen, Leif
    Dudek, Dariusz
    Veldhof, Susan
    Rapoza, Richard
    EUROINTERVENTION, 2010, 6 (04) : 447 - 453
  • [23] Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
    Onuma, Yoshinobu
    Chevalier, Bernard
    Ono, Masafumi
    Cequier, Angel
    Dudek, Dariusz
    Haude, Michael
    Carrie, Didier
    Sabate, Manel
    Windecker, Stephan
    Rapoza, Richard
    West, Nick E. J.
    Reith, Sebastian
    Almeida, Manuel de Sousa
    Campo, Gianluca
    Iniguez, Andres
    Serruys, Patrick W.
    EUROINTERVENTION, 2020, 16 (11) : E938 - E941
  • [24] Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial
    Wiebe, Jens
    Byrne, Robert A.
    Alfonso, Fernando
    Maeng, Michael
    Bradaric, Christian
    Kretov, Evgeny
    Cuesta, Javier
    Kuna, Constantin
    Ibrahim, Tareq
    Rivero, Fernando
    Heugl, Mira
    Christiansen, Evald H.
    Joner, Michael
    Schunkert, Heribert
    Laugwitz, Karl-Ludwig
    Kastrati, Adnan
    Cassese, Salvatore
    EUROINTERVENTION, 2022, 17 (16) : 1348 - +
  • [25] Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
    Kereiakes, Dean J.
    Meredith, Ian T.
    Windecker, Stephan
    Jobe, R. Lee
    Mehta, Shamir R.
    Sarembock, Ian J.
    Feldman, Robert L.
    Dubois, Christophe
    Grady, Timothy
    Saito, Shigeru
    Kimura, Takeshi
    Christen, Thomas
    Allocco, Dominic J.
    Dawkins, Keith D.
    CIRCULATION, 2014, 130 (23) : 2111 - 2111
  • [26] FINAL 5-YEAR OUTCOMES OF THE EVOLVE II TRIAL: A PROSPECTIVE RANDOMIZED INVESTIGATION OF A NOVEL BIOABSORBABLE POLYMER-COATED, EVEROLIMUS-ELUTING SYNERGY STENT
    Kereiakes, Dean J.
    Windecker, Stephan
    Jobe, Robert
    Mehta, Shamir R.
    Sarembock, Ian Joseph
    Feldman, Robert
    Stein, Bernardo
    Dubois, Christophe
    Grady, Timothy
    Saito, Shigeru
    Kimura, Takeshi
    Underwood, Paul
    Allocco, Dominic
    Meredith, Ian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1029 - 1029
  • [27] Clinical outcomes following complete bioresorption of the Absorb everolimus-eluting bioresorbable scaffold: Four-year results from the ABSORB III trial
    Kereiakes, Dean
    Ellis, Stephen
    Stone, Gregg
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B27 - B27
  • [28] Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial
    Arroyo, Diego
    Gendre, Gregoire
    Schukraft, Sara
    Kallinikou, Zacharenia
    Mueller, Olivier
    Baeriswyl, Gerard
    Stauffer, Jean-Christophe
    Goy, Jean-Jacques
    Togni, Mario
    Cook, Stephane
    Puricel, Serban
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 121 - 125
  • [29] The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
    Suwannasom, Pannipa
    Sotomi, Yohei
    Ishibashi, Yuki
    Cavalcante, Rafael
    Albuquerque, Felipe N.
    Macaya, Carlos
    Ormiston, John A.
    Hill, Jonathan
    Lang, Irene M.
    Egred, Mohaned
    Fajadet, Jean
    Lesiak, Maciej
    Tijssen, Jan G.
    Wykrzykowska, Joanna J.
    de Winter, Robbert J.
    Chevalier, Bernard
    Serruys, Patrick W.
    Onuma, Yoshinobu
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (12) : 1231 - 1242
  • [30] Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
    Diego Arroyo
    Mario Togni
    Serban Puricel
    Baeriswyl Gerard
    Lehmann Sonja
    Noé Corpataux
    Hélène Villeneuve
    Estelle Boute
    Jean-Christophe Stauffer
    Jean-Jacques Goy
    Stéphane Cook
    Trials, 15
12345